| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |